Skip to main content

Table 1 Patient and lesion characteristics

From: Impact of Chocolate percutaneous transluminal angioplasty balloon on vessel preparation in drug-coated balloon angioplasty for femoropopliteal lesion

  Chocolate
n = 48
Conventional
n = 63
P
Patient characteristics
 Age, years 74 ± 8 74 ± 9 0.900
 Male, n (%) 36 (75) 46 (73) 0.814
 Body mass index, kg/m2 23.4 ± 4.2 23.2 ± 4.0 0.682
 Hypertension, n (%) 43 (90) 55 (87) 0.711
 Dyslipidemia, n (%) 28 (58) 32 (51) 0.430
 Diabetes mellitus, n (%) 31 (65) 41 (65) 0.957
 Chronic kidney disease, n (%) 31(65) 46(73) 0.340
 Hemodialysis, n (%) 16 (33) 27 (43) 0.308
 Smoker, n (%) 10 (21) 12 (19) 0.815
 Aspirin, n (%) 34 (71) 48 (76) 0.525
 Thienopyridine, n (%) 41 (85) 54 (86) 0.965
 Cilostazol, n (%) 12 (25) 10 (16) 0.232
 Prior Coronary artery disease, n (%) 16 (33) 28 (44) 0.236
 Prior peripheral artery disease, n (%) 22 (46) 31 (49) 0.725
 Prior cerebrovascular disease, n (%) 9 (19) 8 (13) 0.380
 Chronic limb-threatening ischemia, n (%) 10 (21) 19 (30) 0.268
Lesion characteristics
 Pre-ankle brachial index 0.70 ± 0.16 0.65 ± 0.17 0.094
 Post-ankle brachial index 0.93 ± 0.15 0.90 ± 0.19 0.744
 TASCII C/D, n (%) 20 (42) 33 (52) 0.263
 PACSS 3/4, n (%) 24 (50) 33 (52) 0.804
 include P2/3 lesion, n (%) 14 (29) 24 (38) 0.326
 CTO lesion, n (%) 11 (23) 22 (35) 0.170
 Lesion length, mm 134 ± 98 156 ± 96 0.116
 Vessel diameter, mm 4.7 ± 0.7 4.7 ± 0.9 0.468
 poor run off vessel, n (%) 14 (29) 24 (38) 0.326
  1. TASCII Trans-Atlantic Inter-Society Consensus II, PACSS Peripheral Arterial Calcium Scoring System, CTO Chronic total occlusion